A giant cavernous hemangioma of the liver extending into the pelvis  by Kong, Jiayi & Anaya, Daniel A.
CASE REPORT – OPEN ACCESS
International Journal of Surgery Case Reports 13 (2015) 51–54
Contents lists available at ScienceDirect
International Journal of Surgery Case Reports
journa l homepage: www.caserepor ts .com
A giant cavernous hemangioma of the liver extending into the pelvis
Jiayi Konga, Daniel A. Anayaa,b,∗
a Department of Surgery, Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA
b Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (IQUEST), Michael E. DeBakey VA Medical Center, Houston, TX, USA
a r t i c l e i n f o
Article history:
Received 10 June 2015
Accepted 14 June 2015





a b s t r a c t
INTRODUCTION: Giant cavernous hemangiomas are the most common tumors of the liver, ocurring in
up to 20% of the general population. Given their benign course, asymptomatic nature and slow growth
rate, treatment is rarely indicated. The case presented herein is unique as it describes an uncommon
presentation of this common tumor and the circumstances in which surgical treatment is beneﬁcial.
PRESENTATION OF CASE: We present a case of a 66 year-old patient with prostate cancer referred for
evaluation of a massive 37 cm giant liver hemangioma, extending into the pelvis and in the planned ﬁeld
of radiation forprostate cancer, exhibiting rapidgrowth, andassociatedwith signiﬁcant symptomatology.
Given these clinical characteristics, thepatientwasoffered surgery andunderwent a left trisectionectomy
with an uneventful recovery. The patient’s symptoms resolved and he was able to complete radiation to
the pelvis.
DISCUSSION: In the context of an unusual presentation, this case presentation reviews the typical clinical
and imaging characteristics of giant liver hemangiomas and expands on the current indications for treat-
ment, emphasizing the role of enucleation and resection for patients meeting appropriate indications.
CONCLUSION:Although liver hemangiomas are extremely common, surgical treatment is rarely required.
With appropriate indications, andwhen enucleation is not feasible or ideal, major liver resection is a safe
alternative approach with excellent outcomes when performed in the right setting.
Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Hemangiomas are the most common tumors of the liver,
occurring in up to 20% of the general population [1]. Cavernous
liver hemangiomas (CLH) are congenital vascular malformations
that grow by ectasia—rather than hypertrophy, hyperplasia or
neoplasia—therefore resulting in microscopic, and often macro-
scopic, cavernous spaces. CLH range in size from a fewmillimeters
to over 20 cm; those over 5 cm referred to as giant hemangiomas
[2]. Typically, CLH are asymptomatic and found incidentally, but
can occasionally produce symptoms, most commonly abdominal
pain. Bleeding/rupture or symptoms derived from obstruction of
surrounding organs are extremely rare [1,2]. The classic imaging
characteristics of liver hemangiomas include progressive periph-
eral nodular enhancement on dynamic cross-sectional studies (CT
orMRI) anddelayed centripetal ﬁll-in. Treatment is rarely indicated
given their benign course, lack of associated symptomatology and
slow growth rate. We report a case that is particularly interest-
Abbreviations: CLH, cavernous liver hemangiomas; CT, computed tomography;
GH, giant hemangiomas.
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ing given the rare presentation of this fairly common tumor, and
expand on indications for treatment and surgical decision-making.
2. Presentation of case
A 66-year-old man with history of prostate cancer was referred
to the hepatobiliary service for evaluation of a symptomatic and
growing giant liver mass extending within the pelvis, and in the
planned ﬁeld of radiation for the prostate cancer. The patient
reported feeling enlarging abdominal girth for the past 12 months
associated with early satiety and new onset of pain/discomfort.
Abdominal exam revealed a non-tender ﬁrm intra-abdominalmass
extending across the whole abdominal cavity. Laboratory work-
up was not contributory except for a total bilirubin of 1.3mg/dl,
and hepatitis serologies and tumor markers were negative. Cross-
sectional imaging on current presentation revealed a signiﬁcant
increase in the size of themass from 1 year prior (10×21×27 cm),
nowmeasuring 10×25×37 cm.Ondynamic CT themass exhibited
progressive nodular enhancement; however it was very heteroge-
neous containing diffuse large unenhanced cystic components and
lackedevidenceof centripetal ﬁll-in (Fig. 1). It involved themajority
of the liver—sparing only the right posterior section, and extended
down into the pelvis (Fig. 2). Given the tumor’s growth and location
(precluding initiationof radiation therapy) aswell as its symptoma-
tology, the patient was offered surgical treatment—resection.
http://dx.doi.org/10.1016/j.ijscr.2015.06.006
2210-2612/Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Fig. 1. Dynamic computed tomography (axial view) revealing a giant liver mass
with peripheral nodular enhancement during venous/delayed phase—and a large
unenhanced cystic component.
With the diagnosis of giant hemangioma (GH) established the
goal of treatment was to remove the mass while preserving the
majority of uninvolved liver. Preoperative imaging was not able to
discern if clear planes of dissection would be present at the level of
the hilum, although a completely replaced right hepatic artery was
present. On exploration, despite the massive size of the GH, it was
found to be pedunculated and free from the hilar structures allow-
ing for safe dissection (Fig. 3). Early inﬂow control was obtained by
transecting theproper hepatic artery (after conﬁrming the replaced
right hepatic artery was adequate), accomplishing downsizing of
the tumor to 30 cm. Given the mass was encompassing the middle
and left hepatic veins, and transection of these structures would be
necessary for safe and complete resection,we opted for performing
an anatomic resection rather than enucleation of the GH. The trunk
of the middle and left hepatic veins was isolated and transected, in
the formofananatomic left trisectionectomy, althoughasigniﬁcant
Fig. 2. Dynamic computed tomography (coronal view) in venous/delayed phase,
revealing a giant heterogeneous liver mass extending from the diaphragm to the
pubis, and involving the left lobe and right anterior section of the liver.
Fig. 3. View of giant liver hemangioma upon entering the abdomen. Note massive
size as well as pedunculated feature allowing to eviscerate out of the wound, as it
was free from hilar and other abdominal structures.
portion of uninvolved right liver parenchyma was preserved
(Fig. 4). The patient recoveredwell andwas discharged 4 days after
surgery. He is now 9months from resection and has completed
radiation therapy. The preoperative symptoms of pain/discomfort
and early satiety have fully resolved, with normalization of total
bilirubin levels. Recent follow-up CT scan performed for prostate
cancer surveillance revealed adequate hypertrophy of the liver and
no evidence of residual or recurrent hemangioma (Fig. 5).
3. Discussion
We present a case of a patient with a massive giant heman-
gioma (GH) of the liver requiring surgical intervention. This case
is particularly interesting as it highlights a number of uncommon
circumstances not typically seen in patients with liver heman-
giomas. First, the clinical presentation was not characteristic of a
GH given its massive size with unusual extension into the pelvis,
its rapid growth and the associated symptomatology. Further,
despite typical progressive peripheral nodular enhancement on
cross-sectional imaging, the commonﬁndingof delayed centripetal
“ﬁll-in” was absent [3], due to the presence of major cystic com-
ponents. With these unusual clinical and imaging characteristics,
Fig. 4. Surgical specimen—left trisectionectomy, revealing a giant cavernous
hemangiomameasuring 30 cm (after arterial inﬂowcontrol). The specimenweighed
2934g.
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Fig. 5. CT scan 9months after resection revealing staple line at the area of transec-
tion of the middle and left hepatic veins, and hypertrophied right posterior section
of the liver.
the differential diagnosis was broader and included concern for
an underlying neoplasia (i.e., hepatocellular carcinoma or cys-
tadenoma/cystadenocarcinoma). Additional clinical, imaging and
laboratory information were used to narrow the diagnosis so that
appropriate treatment could be established; in the context of no
underlying liver disease, with the pattern of peripheral nodular
and progressive enhancement of a solitary lesion, normal tumor
markers and lack of any distant disease, the preoperative diagnosis
of a giant CLH was conﬁrmed—with the cystic components repre-
senting large cavities with old blood/thrombus from the cavernous
process and intermittent intralesional bleeding, further ruling out
other more malignant processes.
The vast majority of CLH including giant hemangiomas (GH)
have a benign course and require no treatment. When surgery is
performed, themost common indication in adults is pain, followed
by other less common reasons including uncertainty of diagno-
sis, complications such as rupture/bleeding or Kasabach–Merrit
syndrome, and rapid growth [4]. Following hemangioma resec-
tion, pain usually subsides in approximately 63–75% of patients
[2,4], emphasizing the importance of completing a comprehen-
sive work-up for other causes of pain before considering surgical
treatment. This case was also unique given the rapid growth
rate observed. A recent study examining the natural course of
liver hemangiomas found that only ∼40% of CLH exhibit growth
overtime, and for this select group, growth rates are in the
order of 2mm/year [5]. Our case had signiﬁcant growth dur-
ing a 1 year timespan, exceeding the reported growth rates,
and stressing the previously reported association between larger
GH and faster growth rates [5]. Although the faster growth rate
observed in such cases is still poorly understood, it may be
related to intralesional bleeding, as the cystic component with
blood/thrombus represented the primary contributor of growth in
our patient.
Treatment options for GH include arterial embolization and
surgery for enucleation, resection or transplantation (rarely)
[1,2,4]. A number of studies comparing the outcomes of resection
andenucleationhave foundenucleation tobeassociatedwith lower
risk of postoperative complications (primarily bile leak), and is cur-
rently thepreferredapproach [6]. Resection remainsanappropriate
alternative for cases inwhich the extent of the hemangioma is such
that transection of major vascular structures is required and enu-
cleation across these areas, although feasible is less safe and not
ideal (as occurred in this case). In this setting, major liver resec-
tions including “super-extended resections” have been reported to
be safe and associated with excellent outcomes when performed
in high-volume centers [4,7].
4. Conclusion
Cavernous liver hemangiomas are the most common liver
tumor, often presenting as giant hemangiomas (>5 cm). These
tumors are typically asymptomatic and exhibit very slow growth
rates. Treatment is rarely indicated. The case presented herein rep-
resents an ideal example of an uncommon presentation of this
common tumorand the circumstances inwhich surgery is required.
Almost invariably, surgery is only indicated for very large giant
hemangiomas presenting with associated symptoms (most com-
monly abdominal pain), rapid growth, and/or when the diagnosis
is uncertain (rarely).When the appropriate indications are present,
enucleation is the preferred surgical approach. When enucleation
is not ideal, major liver resection is a reasonable and safe alterna-
tive, with excellent outcomes when performed in the appropriate
setting.
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